| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Zhejiang Xinguang Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥11.25 |
| 52 Week High | CN¥19.88 |
| 52 Week Low | CN¥8.45 |
| Beta | 0.20 |
| 1 Month Change | -13.59% |
| 3 Month Change | -12.04% |
| 1 Year Change | -29.69% |
| 3 Year Change | -29.11% |
| 5 Year Change | -21.88% |
| Change since IPO | 28.06% |
Recent News & Updates
Zhejiang Xinguang Pharmaceutical (SZSE:300519) Has Announced That Its Dividend Will Be Reduced To CN¥0.40
May 26
Calculating The Intrinsic Value Of Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE:300519)
Apr 16Recent updates
Zhejiang Xinguang Pharmaceutical (SZSE:300519) Has Announced That Its Dividend Will Be Reduced To CN¥0.40
May 26Calculating The Intrinsic Value Of Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE:300519)
Apr 16Zhejiang Xinguang Pharmaceutical Co., Ltd.'s (SZSE:300519) Low P/E No Reason For Excitement
Feb 26Shareholder Returns
| 300519 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -0.2% | -1.1% | 0.06% |
| 1Y | -29.7% | -12.5% | -16.1% |
Return vs Industry: 300519 underperformed the CN Pharmaceuticals industry which returned -11.9% over the past year.
Return vs Market: 300519 underperformed the CN Market which returned -15.5% over the past year.
Price Volatility
| 300519 volatility | |
|---|---|
| 300519 Average Weekly Movement | 5.8% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.2% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 300519 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300519's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 315 | Yue Jun Wang | www.xgpharma.com |
Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food. It offers pharmaceutical products for vascular and trauma diseases, including respiratory system, digestive system, urinary system, pediatric diseases, and improving immunity. The company was incorporated in 1998 and is headquartered in Shengzhou, China.
Zhejiang Xinguang Pharmaceutical Co., Ltd. Fundamentals Summary
| 300519 fundamental statistics | |
|---|---|
| Market cap | CN¥1.80b |
| Earnings (TTM) | CN¥56.74m |
| Revenue (TTM) | CN¥278.65m |
31.7x
P/E Ratio6.5x
P/S RatioIs 300519 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300519 income statement (TTM) | |
|---|---|
| Revenue | CN¥278.65m |
| Cost of Revenue | CN¥177.75m |
| Gross Profit | CN¥100.89m |
| Other Expenses | CN¥44.15m |
| Earnings | CN¥56.74m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.35 |
| Gross Margin | 36.21% |
| Net Profit Margin | 20.36% |
| Debt/Equity Ratio | 0% |
How did 300519 perform over the long term?
See historical performance and comparison